1- Abhilash, M.; Paul, M.V.; Varghese, M.V.; Nair, R.H. (2011): Effect of long term intake of aspartame on antioxidant defense status in liver, Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc., 49:1203–1207.
2-Ager, D.J.; Pantaleone , D.P.; Henderson, S.A.; Katritzky, A.R.; Prakash, I.; Walters, D.E. (1998): "Commercial, Synthetic Non-nutritive Sweeteners".
Angewandte Chemie International Edition, 37: (13–24): 1
Alipour, M.C. (2013): Therapeutic effect of liposomal-N-acetylcysteine against acetaminophen-induced hepatotoxicity. J Drug Target, Early Online. 1–8. 802–1817.
3-Ashok, D.W.; Rathinasamy, S.W.(2014): Long-term effect of aspartame on the liver antioxidant status and histopathology in Wistar albino rats. Biomedicine & Preventive Nutrition. 4 (2): 299–05.
4-Budavari, S. (1989): Aspartame. The Merck Index (11th ed.). Rahway, NJ: Merck & Co. p. 859-861.
5-Butchko, H.H.; Stargel , W.W.; Comer, C.P.; Mayhew, D.A.; Benninger, C.and Blackburn, G.L.( 2002) : Aspartame: review of safety. Regulatory Toxicology and Pharmacology. 35 (2 Pt 2): S1–93.
6-Choudhary, A.K. and Pretorius, E. (2017): Revisiting the safety of aspartame". Nutrition reviews. 75 (9): 718–730.
7-Darwish, A.; Eman, S.h. M.G. and El-Said (2015): Effect of N-acetylcysteine (NAC) On Hepatotoxicity of Aspartame. Egypt. J. Chem. Environ. Health, 1 (1):389-399.
9-Egbuonu, A. C. (2009): Hepatotoxic effects of low dose oral administration of monosodium glutamate in male albino rats. African Journal of Biotechnology .8 (13) 303-35.
10-Humphries, P.; Pretorius, E. and Naudé , H. (2008): Direct and indirect cellular effects of aspartame on the brain. European Journal of Clinical Nutrition. 62 (4): 451–62.
11-James, B. (2000): Mal sexual dysfunction triggered by aspartame. The spectrum (1), 11.p 8.
13-Kirkland, D. and Gatehouse, D. (2015): Aspartame: A review of genotoxicity data. Food and Chemical Toxicology. 84: 161–8.
14-Magnuson, B.A . ; Burdock , G.A . ; Doull , J . ; Kroes , R.M . ; Marsh , G . M.; Pariza, M.W.; Spencer, P.S.; Waddell, W.J.; Walker, R. and Williams G.M. (2007): Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Crit. Rev. Toxicol., 37(8): 629-727.
15-Marinovich, M.; Galli, C.L.; Bosetti, C.; Gallus, S.and La Vecchia, C. (2013): Aspartame, low-calorie sweeteners, and disease: regulatory safety and epidemiological issues. Food and Chemical Toxicology. 60: 109–15.
17-Millichap, J.G. and Yee, M.M. (2003): The diet factor in pediatric and adolescent migraine. Pediatric Neurology. 28 (1): 9–15.
19-Ozer, J. (2008): The current state of serum biomarkers of hepatotoxicity. Toxicology. 20; 245(3):194-05.
20-Puica, C . ; Craciun, C.; Rusu, M.; Cristescu, M . ; Borsa, M . and Roman, I. (2009):Ultrastructural aspects concerning the hypothalamus-pituitary complex reactivity following chronic administration of aspartame in juvenile rats. Studia Universitatis “Vasile Goldiş” Seria Ştiințele Vieţii, 19(1), 19-24.
21-Renwick, A.G. (2006): The intake of intense sweeteners - an updated review. Food Additives and Contaminants. 23 (4): 327–38.
22-Stegink, L .D. (1987): The aspartame story: a model for the clinical testing of a food additive. The American Journal of Clinical Nutrition. 46 (1 Suppl): 204–15.
23-Stegink, L. D . ; Filer, L.J., and Baker, G.L. (1979): Plasma, erythrocyte and human milk levels of free amino acids in lactating women administered aspartame or lactose. The Journal of Nutrition. 109 (12): 2173–81.
24-Sun-Edelstein, C. and Mauskop, A . (2009): Foods and supplements in the management of migraine headaches. The Clinical Journal of Pain. 25 (5): 446–52.